Naltrexone treatment for opioid use disorder is one of the most clinically validated tools in addiction medicine, yet many people weighing their options still don’t fully understand how it works or whether they’re a good candidate. This article breaks down the mechanism, the requirements, the tradeoffs, and what a real treatment course actually looks like, so you can make an informed decision about your next step.
What Is Naltrexone?
Naltrexone is an FDA-approved, non-addictive medication used in medication-assisted treatment (MAT) for opioid use disorder. The FDA first approved it for opioid use disorder in 1984, and the extended-release injectable form (Vivitrol) received approval in 2010. It is not an opioid. It carries no abuse potential and produces no high. Its job is purely pharmacological: block opioid receptors so that opioids cannot do what they normally do in the brain.
That distinction matters more than it might seem at first. Choosing naltrexone is not trading one substance for another. It is removing the neurological reward that makes opioids so difficult to stop using.
How Naltrexone Works in the Brain
When you take an opioid, it binds to mu-opioid receptors in your brain and triggers a release of dopamine, producing euphoria and pain relief. Naltrexone works by attaching to those same receptors first, blocking opioids from binding at all. With the receptor occupied, opioids produce no euphoria, no relief, and no reward.
A 2016 review published in the Cochrane Database of Systematic Reviews, covering 13 randomized controlled trials, confirmed that naltrexone significantly reduces opioid use in people who remain on the medication. The key phrase there is “remain on the medication,” which is why delivery method matters as much as the drug itself.
The Difference Between Blocking and Replacing
Methadone and buprenorphine work by activating opioid receptors to a controlled degree, which reduces cravings and prevents withdrawal. Naltrexone does something categorically different: it blocks the receptors entirely without activating them. There is no opioid activity, no physical dependence on the medication, and no risk of diversion.
For someone in early recovery who wants a non-opioid path, this is a meaningful clinical distinction. You are not maintaining a low-level opioid state. You are pharmacologically removing the possibility of getting high, which changes the calculus of relapse in a very direct way.
Extended-Release vs. Oral Naltrexone
Naltrexone comes in two forms. The daily oral tablet, sold as ReVia, requires consistent self-administration. The monthly injectable, Vivitrol, is administered by a clinician once every four weeks. Adherence data consistently favors the injectable. A 2018 study published in The Lancet found that extended-release injectable naltrexone and extended-release buprenorphine produced comparable outcomes when patients actually initiated treatment, but that initiation and adherence were stronger predictors of success than the medication itself.
The practical advantage of Vivitrol is straightforward: it eliminates the daily decision. You cannot forget a dose mid-month, and you cannot choose to skip it the night cravings spike. For most people managing opioid use disorder, removing that daily friction point improves outcomes meaningfully.
Who Naltrexone Is Right For
The right candidate for naltrexone is someone who has already completed medically supervised opioid detox and has been opioid-free for a minimum of 7 to 10 days. That is not a bureaucratic hurdle. It is a medical requirement with serious consequences if ignored.
Naltrexone works within a structured plan, not as a standalone fix. Understanding what a full MAT program actually involves before you start is worth the time, because medication without behavioral support leaves the psychological half of addiction unaddressed.
The Opioid-Free Requirement Before Starting
Starting naltrexone before opioids fully clear your system triggers precipitated withdrawal: a sudden, severe onset of withdrawal symptoms caused by the medication forcibly displacing opioids from receptors. Precipitated withdrawal is not the same as regular withdrawal. It is faster, more intense, and can begin within minutes of the first dose. Symptoms include severe muscle cramping, rapid heart rate, vomiting, and extreme agitation.
This is exactly why medical supervision during the transition is not optional. A physician can confirm opioid clearance through clinical assessment and, where indicated, a naloxone challenge test before induction begins.
Who Should Not Take Naltrexone
Naltrexone is contraindicated for anyone still actively dependent on opioids without completing detox, anyone experiencing acute hepatitis or liver failure, and anyone who requires opioid-containing medications for pain management, since naltrexone will block their effect entirely. Naltrexone requires a physician evaluation. It is not a medication to self-prescribe or source outside a clinical setting.
Naltrexone vs. Other Medications for Opioid Use Disorder
The three primary medications approved for opioid use disorder are methadone, buprenorphine/naloxone (Suboxone), and naltrexone. Each has a distinct clinical profile. Methadone is a full opioid agonist dispensed through federally regulated clinics and requires daily visits, at least initially. Buprenorphine is a partial agonist that can be prescribed in office-based settings. Naltrexone is a full antagonist with no opioid activity.
The tradeoff with naltrexone is front-loaded: the detox requirement is a real barrier for many people, since completing 7 to 10 days opioid-free before induction is harder than starting buprenorphine relatively quickly after last use. But once initiated, naltrexone carries no diversion risk, no physical dependence, and no DEA prescribing restrictions beyond a standard physician license. For someone motivated to pursue a fully opioid-free pharmacological path, it is a clinically sound option. If you want to compare how buprenorphine induction works as an alternative starting point, what to expect during a buprenorphine induction is a useful reference.
Side Effects and Safety Considerations
Common side effects of naltrexone include nausea, headache, fatigue, difficulty sleeping, and reduced appetite. Most are mild and tend to diminish over the first few weeks. The more serious concern is hepatotoxicity: at very high doses, naltrexone carries a risk of liver damage. SAMHSA’s clinical guidelines note that at prescribed therapeutic doses, naltrexone is safe for most patients, but liver function monitoring is warranted for anyone with pre-existing hepatic conditions. A physician will assess this before prescribing.
Reduced Opioid Tolerance and Overdose Risk
Here is the safety warning that does not get enough attention: naltrexone reduces your opioid tolerance during the blocking period. If you stop taking naltrexone and then use opioids at a dose that previously felt normal, the overdose risk is severe. The tolerance your body built before treatment no longer applies.
This is one of the strongest reasons that naltrexone belongs inside a structured treatment program, not outside one. The medication manages biological craving. It does not manage the moment you decide to stop taking it.
What Naltrexone Treatment Actually Looks Like
A realistic treatment course follows a clear sequence. First, medically supervised detox to clear opioids safely. Then a clearance window of 7 to 10 days minimum. Then clinical induction onto naltrexone, oral or injectable, with ongoing monitoring and regular contact with the prescribing physician. Throughout that timeline, behavioral therapy runs in parallel.
A 2014 SAMHSA report on extended-release injectable naltrexone found that patients receiving Vivitrol showed significantly higher rates of opioid-negative urine screens at 6 months compared to those who received placebo, with the injectable format showing stronger retention than oral dosing in real-world settings. Retention in treatment consistently predicts better long-term outcomes across every form of MAT.
For a broader picture of how different medications fit into a full treatment plan, a guide to medications used across the spectrum of opioid treatment covers the clinical landscape in depth.
The Role of Therapy Alongside Naltrexone
Naltrexone handles the biological piece: craving reduction and reward blockade. It does not address the psychological patterns, trauma history, or mental health conditions that often sit underneath opioid use disorder. That gap is where behavioral therapy becomes essential.
A 2017 NIDA-funded trial found that extended-release naltrexone combined with behavioral therapy produced significantly better outcomes than medication alone, with improvements in depression symptoms, quality of life, and sustained abstinence at 12 months. Cognitive behavioral therapy, contingency management, and peer support are what close the gap the medication cannot reach. This is why programs that pair structured medication management with mental health treatment produce stronger results than either approach on its own.
How to Access Naltrexone Treatment
Start with a licensed addiction medicine physician or a certified treatment center that offers MAT evaluation. The evaluation will assess your medical history, current opioid use, liver function, and whether you’ve completed or are ready to begin supervised detox. If you haven’t yet completed detox, that becomes the first clinical priority.
Vivitrol does not require a DEA waiver to prescribe, unlike methadone, which means access through addiction treatment centers is more straightforward. A qualified program will walk you through the induction process step by step and coordinate the behavioral health support that makes naltrexone effective rather than just administered.
The First Phone Call Is Not a Commitment
You do not have to decide today whether naltrexone is the right choice for you. That decision happens with a physician, after an evaluation, with your full history on the table. What you can do this week is make one phone call to a licensed addiction treatment center and ask two specific questions: Am I a candidate for naltrexone, and is medically supervised detox the right first step?
That conversation will tell you more than any article can. It is also the only step that actually moves things forward.